TORONTO, Jan. 10, 2014 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today full year results for fiscal 2013.

Highlights for the year include:

-- Revenues for the year increased to $1,023.1 million from $749.1 million
in the same period last year, an increase of $274.0 million or 36.6